Setmelanotide
Back to searchMolecule Structure
Scientific Name
Setmelanotide
Description of the Drug
Setmelanotide is setmelanotide is indicated to treat obesity caused by genetic POMC, PCSK1, or LEPR deficiencies or Bardet-Biedl syndrome.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11700
http://www.drugbank.ca/drugs/DB11700
Brand Name(s)
Not Available
Company Owner(s)
Rhythm Pharmaceuticals Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Melanocortin receptor 4 | SINGLE PROTEIN | AGONIST | CHEMBL259 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL21840385 |
| Human Metabolome Database | HMDB0304856 |
| DrugBank | DB11700 |
| PubChem: Thomson Pharma | 17492841 |
| PubChem | 11993702 |
| DrugCentral | 5416 |
| Guide to Pharmacology | 9272 |
